Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive disease.

Lu, Yujie; Tong, Yiwei; Fei, Xiaochun; Chen, Xiaosong; Shen, Kunwei

Lu, Yujie; Tong, Yiwei; Fei, Xiaochun; Chen, Xiaosong; Shen, Kunwei.

Afiliação

Lu Y; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tong Y; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fei X; Department of Pathology, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen X; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen K; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Cancer Med ; 12(15): 16264-16278, 2023 08.

Article em En | MEDLINE | ID: mdl-37366301

Assuntos

Neoplasias da Mama; Linfócitos do Interstício Tumoral; Biomarcadores Tumorais; Intervalo Livre de Doença; Hibridização in Situ Fluorescente; Prognóstico; Receptor ErbB-2; Estudos Retrospectivos; Neoplasias da Mama/diagnóstico

Palavras-chave

HER2-low; breast cancer; sTILs; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos do Interstício Tumoral Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google